| EP0820323 - METERED DOSE INHALER FOR SALMETEROL [Right-click to bookmark this link] | Status | Patent revoked Status updated on 29.08.2008 Database last updated on 21.03.2026 | Most recent event Tooltip | 29.08.2008 | Revocation of patent | published on 01.10.2008 [2008/40] | Applicant(s) | For all designated states SMITHKLINE BEECHAM CORPORATION One Franklin Plaza, P.O. Box 7929 Philadelphia Pennsylvania 19101-7929 / US | [N/P] |
| Former [2002/47] | For all designated states SmithKline Beecham Corporation One Franklin Plaza, P.O. Box 7929 Philadelphia, Pennsylvania 19101-7929 / US | ||
| Former [1998/05] | For all designated states GLAXO WELLCOME INC. 5 Moore Drive, Box 13398 Research Triangle Park, North Carolina 27709 / US | Inventor(s) | 01 /
ASHURST, Ian, C. Glaxo Wellcome Inc. 5 Moore Drive Research Triangle Park, NC 27709 / US | 02 /
HERMAN, Craig, S. Glaxo Wellcome Inc. 5 Moore Drive Research Triangle Park, NC 27709 / US | 03 /
LI, Li Glaxo Wellcome Inc. 5 Moore Drive Research Triangle Park, NC 27709 / US | 04 /
RIEBE, Michael, T. Glaxo Wellcome Inc. 5 Moore Drive Research Triangle Park, NC 27709 / US | 05 /
BRITTO, Ignatius Loy Glaxo Wellcome Inc., 5 Moore Drive PO Box 13398, NC 27709-3398 / US | [2000/03] |
| Former [1998/05] | 01 /
ASHURST, Ian, C. Glaxo Wellcome Inc. 5 Moore Drive Research Triangle Park, NC 27709 / US | ||
| 02 /
HERMAN, Craig, S. Glaxo Wellcome Inc. 5 Moore Drive Research Triangle Park, NC 27709 / US | |||
| 03 /
LI, Li Glaxo Wellcome Inc. 5 Moore Drive Research Triangle Park, NC 27709 / US | |||
| 04 /
RIEBE, Michael, T. Glaxo Wellcome Inc. 5 Moore Drive Research Triangle Park, NC 27709 / US | Representative(s) | Cooke, Tracey GlaxoSmithKline Global Patents (CN925.1) 980 Great West Road Brentford, Middlesex TW8 9GS / GB | [N/P] |
| Former [2005/40] | Cooke, Tracey GlaxoSmithKline, Corporate Intellectual Property (CN9.25.1), 980 Great West Road Brentford Middlesex TW8 9GS / GB | ||
| Former [2005/32] | Cooke, Tracey GlaxoSmithKline Corporate Intellectual Property Two New Horizons Court Brentford, Middlesex TW8 9EP / GB | ||
| Former [1998/05] | Quillin, Helen Kaye, et al Glaxo Wellcome plc Glaxo Wellcome House, Berkeley Avenue Greenford, Middlesex UB6 0NN / GB | Application number, filing date | 96911712.6 | 10.04.1996 | [1998/05] | WO1996US05005 | Priority number, date | US19950422370 | 14.04.1995 Original published format: US 422370 | US19960583332 | 05.01.1996 Original published format: US 583332 | [1998/05] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO9632150 | Date: | 17.10.1996 | Language: | EN | [1996/46] | Type: | A1 Application with search report | No.: | EP0820323 | Date: | 28.01.1998 | Language: | EN | The application published by WIPO in one of the EPO official languages on 17.10.1996 takes the place of the publication of the European patent application. | [1998/05] | Type: | B1 Patent specification | No.: | EP0820323 | Date: | 24.09.2003 | Language: | EN | [2003/39] | Search report(s) | International search report - published on: | EP | 17.10.1996 | Classification | IPC: | A61M15/00, B65D83/14 | [2003/15] | CPC: |
B65D83/52 (EP,US);
A61M15/00 (KR);
A61M15/009 (EP,US);
A61M2205/0222 (EP,US);
A61M2205/0233 (EP,US)
|
| Former IPC [1998/05] | A61M15/00, B65D83/14, B05D5/08 | Designated contracting states | AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [1998/05] | Extension states | AL | 03.10.1997 | LT | 03.10.1997 | LV | 03.10.1997 | SI | 03.10.1997 | Title | German: | DOSIERINHALATOR FÜR SALMETEROL | [1998/05] | English: | METERED DOSE INHALER FOR SALMETEROL | [1998/05] | French: | INHALATEUR DOSEUR DE SALMETEROL | [1998/05] | Entry into regional phase | 03.10.1997 | National basic fee paid | 03.10.1997 | Designation fee(s) paid | 03.10.1997 | Examination fee paid | Examination procedure | 07.11.1996 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 03.10.1997 | Examination requested [1998/05] | 21.06.1999 | Amendment by applicant (claims and/or description) | 08.04.2002 | Despatch of a communication from the examining division (Time limit: M05) | 16.09.2002 | Reply to a communication from the examining division | 20.03.2003 | Communication of intention to grant the patent | 04.07.2003 | Fee for grant paid | 04.07.2003 | Fee for publishing/printing paid | Divisional application(s) | EP03017935.2 / EP1366777 | EP05075583.4 / EP1547636 | EP07025253.1 / EP1908488 | Opposition(s) | Opponent(s) | 01
24.06.2004
ADMISSIBLE 3M Innovative Properties Company 3M Center P.O. Box 33427 St. Paul MN 55133-3427 / US Opponent's representative Aleandri-Hachgenei, Lorraine E. 3M Deutschland GmbH Office of Intellectual Property Counsel Carl-Schurz-Strasse 1 41453 Neuss / DE | [N/P] |
| Former [2004/34] | |||
| Opponent(s) | 01
24.06.2004
ADMISSIBLE 3M Innovative Properties Company 3M General Offices St. Paul P.O. Box 33427 St. Paul, Minnesota 55133-3427 / US Opponent's representative Aleandri-Hachgenei, Lorraine E. 3M Deutschland GmbH, Office of Intellectual Property Counsel, Carl-Schurz-Strasse 1 41453 Neuss / DE | 03.08.2004 | Invitation to proprietor to file observations on the notice of opposition | 14.02.2005 | Reply of patent proprietor to notice(s) of opposition | 30.11.2005 | Date of oral proceedings | 21.12.2005 | Despatch of interlocutory decision in opposition | 21.12.2005 | Despatch of minutes of oral proceedings | 28.02.2008 | Legal effect of revocation of patent [2008/40] | 28.02.2008 | Despatch of communication that the patent will be revoked | Appeal following opposition | 17.02.2006 | Appeal received No. T0226/06 | 20.04.2006 | Statement of grounds filed | 28.02.2008 | Result of appeal procedure: revocation of the patent | 28.02.2008 | Date of oral proceedings | Fees paid | Renewal fee | 14.04.1998 | Renewal fee patent year 03 | 14.04.1999 | Renewal fee patent year 04 | 13.04.2000 | Renewal fee patent year 05 | 12.04.2001 | Renewal fee patent year 06 | 12.04.2002 | Renewal fee patent year 07 | 07.04.2003 | Renewal fee patent year 08 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | |||